Results 11 to 20 of about 23,888 (239)
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2021 restriction
Yeongjoo, Oh +2 more
openaire +4 more sources
Non-Langerhans cell histiocytosis in a child with Kawasaki disease
BMJ Case Reports, 2009 Polymorphous skin rashes are one of the major presentations in children with Kawasaki disease. This report describes an unusual presentation of a skin rash (non-Langerhans cell histiocytosis) in a 4-month-old baby with resistance to intravenous immunoglobulin (IVIG) treatment and coronary artery dilatation.
Ho-Chang, Kuo +6 more
openaire +4 more sources
Synovial Non-langerhans Cell Histiocytosis of the Shoulder: A Case Report and Review of the Literature. [PDF]
J Orthop Case Rep, 2020 Histiocytoses are rare disorders and most orthopedic surgeons are unfamiliar with this diagnosis. We report a case of synovial non-Langerhans cell histiocytosis (LCH) located in the shoulder, which has not been reported in the literature previously.A 24-year-old female patient presented to our clinic with shoulder pain and decreased range of motion ...
Huri G +3 more
europepmc +3 more sources
MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis
Blood, 2019 Background: Activation of the MAPK pathway through BRAF mutations or other molecular alterations is a hallmark of the non-Lagerhans cell histiocytosis (non-LCH) such Erdheim-Chester disease (ECD) or Rosai-Dorfman disease (RDD). Conventional clinical molecular testing of tumor tissue fails to identify targetable molecular alteration in about one third ...
Filip Janku +5 more
openaire +2 more sources
A case of Langerhans cell histiocytosis mimicking child abuse
The Turkish Journal of Pediatrics, 2016 Langerhans cell histiocytosis is a rare non-malignant disease with clinical heterogeneity. The disease may present with various clinical findings and may imitate many other conditions.
Şakire Başer +9 more
doaj +3 more sources
Frontiers in ImmunologyAims Early detection and treatment of neurodegenerative Langerhans cell histiocytosis (ND-LCH) have been suggested to prevent neurodegenerative progression.
Irène Trambusti +2 more
exaly +2 more sources
Blood, 2005 AbstractErdheim-Chester disease is a rare non-Langerhans histiocytosis with multisystem involvement. To date, there is no standard treatment for this disorder, and more than half of the patients succumb within 3 years. Because interferon-α promotes the terminal differentiation of histiocytes and dendritic cells, we hypothesized that this molecule would
Fadi, Braiteh +3 more
openaire +3 more sources
Case report: Pulmonary non-Langerhans cell histiocytosis in a dog with acute interstitial granulomatous pneumonia. [PDF]
Front Vet SciGranger KL +4 more
europepmc +2 more sources
Renovascular Hypertension: Unraveling a Case of Mixed Histiocytosis
Annals of Internal Medicine: Clinical Cases, 2023 Renovascular hypertension is a cause of secondary hypertension. Atherosclerotic renal artery stenosis and fibromuscular dysplasia are the main causes, but other rare entities can involve the renal arteries.
Pedro Marques +8 more
doaj +1 more source
Adult-onset of Langerhans cell histiocytosis: a clinical case
Alʹmanah Kliničeskoj Mediciny, 2021 Langerhans cell histiocytosis is mainly diagnosed in children, and its manifestation in adult age is quite uncommon. Skin rashes may be non-specific and mimic a number of dermatoses.
Olga V. Chernysheva +3 more
doaj +1 more source